ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGregor, C. G.
Right arrow Articles by McDougall, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGregor, C. G.
Right arrow Articles by McDougall, J. C.

The Annals of Thoracic Surgery, Vol 57, 1513-1520, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Evolving strategies in lung transplantation for emphysema

CG McGregor, RC Daly, SG Peters, DE Midthun, JP Scott, MS Allen, HD Tazelaar, MR Keating, RC Walker and JC McDougall
Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905.

Evolving strategies of pulmonary preservation, bronchial revascularization, immunosuppression, and infectious disease management were used in 15 initial consecutive patients undergoing lung transplantation for emphysema. There were 10 women and 5 men with a mean age of 49 years (range, 36 to 60 years). All patients required supplemental oxygen therapy. One bilateral, 9 left, and 5 right transplantations were performed. Mean preoperative forced expiratory volume in 1 second and total lung capacity were 16% and 146%, respectively, of predicted. Quadruple drug immunosuppression was used. Actuarial 1-year survival in this initial series is 93.3% +/- 6.4% (Kaplan-Meier) with one early cardiac death at day 71. Mean forced expiratory volume in 1 second and diffusing capacity for carbon monoxide at discharge were 43% and 62%, respectively, of predicted. Rehabilitation has been excellent, and all survivors are active and free of supplemental oxygen. During the study, the following treatment strategies have evolved: (1) University of Wisconsin solution has replaced Euro-Collins' solution for pulmonary preservation; (2) direct bronchial revascularization with the internal thoracic artery now is used; (3) an algorithm-based variable dose OKT3 induction regimen has resulted in a major reduction in dosage; and (4) infectious disease management focuses on the prophylaxis of cytomegalovirus and fungal infection using prolonged ganciclovir and early itraconazole therapy as well as the avoidance of Epstein-Barr virus mismatches. Single-lung transplantation for emphysema has excellent early results with continuing evolving management strategies.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Fiser, C. G. Tribble, A. K. Kaza, S. M. Long, J. A. Kern, D. C. Cassada, J. Linden, J. Rieger, V. E. Laubach, A. Matisoff, et al.
Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion
J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 973 - 978.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Dakin and M Griffiths
The pulmonary physician in critical care 1: Pulmonary investigations for acute respiratory failure
Thorax, January 1, 2002; 57(1): 79 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Fiser, C. G. Tribble, S. M. Long, A. K. Kaza, J. T. Cope, V. E. Laubach, J. A. Kern, and I. L. Kron
Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1069 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. M. Fiser, C. G. Tribble, S. M. Long, A. K. Kaza, J. A. Kern, and I. L. Kron
Pulmonary macrophages are involved in reperfusion injury after lung transplantation
Ann. Thorac. Surg., April 1, 2001; 71(4): 1134 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
R. C Cook, G. Fradet, D. Ostrow, and B. Nelems
Lung Volume Reduction Surgery Following Single-Lung Transplantation
Asian Cardiovasc Thorac Ann, September 1, 1999; 7(3): 221 - 224.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. A. Norgaard, P. S. Olsen, U. G. Svendsen, and G. Pettersson
Revascularization of the Bronchial Arteries in Lung Transplantation: An Overview
Ann. Thorac. Surg., October 1, 1996; 62(4): 1215 - 1221.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Aarnio, H. Schersten, H. D. Tazelaar, V. M. Miller, and C. G. A. McGregor
EFFECTS OF ACUTE REJECTION AND ANTIREJECTION THERAPY ON ARTERIES AND VEINS FROM CANINE SINGLE LUNG ALLOGRAFTS
J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1219 - 1229.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.